Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7252924

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-2,893,000,000 JPY
1,280,000,000 JPY
Interest and dividends received
107,000,000 JPY
96,000,000 JPY
Interest paid
-143,000,000 JPY
-170,000,000 JPY
Income taxes paid
-374,000,000 JPY
-578,000,000 JPY
Net cash provided by (used in) operating activities
-3,305,000,000 JPY
627,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,122,000,000 JPY
-3,245,000,000 JPY
Net cash provided by (used in) investing activities
-3,168,000,000 JPY
-3,536,000,000 JPY
Proceeds from sale of investment securities
JPY
84,000,000 JPY
Other, net
-70,000,000 JPY
-32,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-4,000,000 JPY
-652,000,000 JPY
Dividends paid
-638,000,000 JPY
-645,000,000 JPY
Proceeds from long-term borrowings
1,300,000,000 JPY
4,900,000,000 JPY
Repayments of long-term borrowings
-8,382,000,000 JPY
-3,587,000,000 JPY
Net cash provided by (used in) financing activities
7,618,000,000 JPY
14,000,000 JPY
Other, net
-3,000,000 JPY
0 JPY
Net increase (decrease) in cash and cash equivalents
1,144,000,000 JPY
-2,894,000,000 JPY
Cash and cash equivalents
6,264,000,000 JPY
5,120,000,000 JPY
8,014,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.